Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bluetongue 'shaped by ability to re-assort genes'
sheep
"By introducing live attenuated virus vaccines, we may be contributing to the genetic variation of BTV."

New study may have implications for live vaccine use
 
The repeated emergence of bluetongue virus (BTV) in European livestock has been shaped by its ability to re-assort its genes, scientists say.

Findings from a new study also suggest the use of live virus vaccines may be contributing to the development new BTV strains.

The virus - which affects ruminants such as cattle and sheep - is spread by biting midges and can be fatal. It also has indirect impacts such as weight loss, reduced milk production, abortions and deformed calves.

Until the late 1990s, it was thought to be absent from most of Europe, but since then, multiple strains have emerged, with new strains appearing each year.

An outbreak that started in the Netherlands in 2006 spread across the whole European community, causing the deaths of more than two million sheep.

It is a segmented virus, which means its genome is divided into multiple parts.

When the same cell is infected by two segmented viruses of the same species, their progeny can incorporate segments from either of the 'parent' viruses. This process is known as 're-assortment' and it is an important factor in the creation of zoonotic flu strains, such as avian and swine flu.

Scientists from the University of Glasgow and the Pirbright Institute analysed the re-assortment patterns of BTV in Europe.

Dr Roman Biek said that while much attention has been paid to re-assortment in certain viruses - particularly influenza A - its frequency and biological consequences remain poorly understood in many others.

The team's findings have important implications for the use of live vaccines to control outbreaks, he added. "By introducing live attenuated virus vaccines, we may be contributing to the genetic variation of BTV, and the creation of novel strains whose properties we know nothing about.

"This needs to be considered during the design and implementation of control strategies."

The findings have been published in the journal PLoS Pathogens.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.